Literature DB >> 10603633

Induced sputum compared to bronchoalveolar lavage for evaluating patients with sarcoidosis and non-granulomatous interstitial lung disease.

E Fireman1, I Topilsky, J Greif, Y Lerman, Y Schwarz, A Man, M Topilsky.   

Abstract

Bronchoalveolar lavage (BAL), an important tool for evaluating interstitial lung diseases (ILDs), has limited utility due to its invasiveness and the difficulty of performing it in clinically contraindicated patients. We compared BAL with the induced sputum (IS) technique to analyse cells and T lymphocytes in patients with sarcoidosis (SA) and non-granulomatous ILD (NG-ILD). Pulmonary function tests and BAL were performed by conventional methods. IS induction was done 20 sec after inhalation of 3.5% saline with an ultrasonic nebulizer. Giemsa-stained cytopreps were differentially counted. T lymphocyte subsets were analysed by flow activated cell sorter (FACS). Patients with NG-ILD had impaired total lung capacity (TLC). Transbronchial biopsy demonstrated lung fibrosis in NG-ILD and non-caseating granuloma in SA. The differential cell count in both groups demonstrated a significantly lower percentage of neutrophils and a significantly higher percentage of macrophages in BAL than in IS. The IS samples of patients with SA were significantly richer in metachromatic cells and eosinophils, but had a lower percentage of lymphocytes, compared to the BAL samples. The profiles of T cell subsets showed the same pattern, in both samples, in both groups. A CD4/CD8 ratio of 2.5 or greater had a sensitivity of 100% and a specificity of 81.2%, with a positive predictive value of 81.2% to distinguish SA from NG-ILD. IS is an effective non-invasive technique to identify CD4+ inflammation which distinguishes sarcoidosis from other NG-ILDs.

Entities:  

Mesh:

Year:  1999        PMID: 10603633     DOI: 10.1016/s0954-6111(99)90269-x

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  13 in total

1.  A novel alternative to environmental monitoring to detect workers at risk for beryllium exposure-related health effects.

Authors:  Elizabeth Fireman; Yehuda Lerman; Moshe Stark; Asher Pardo; Yehuda Schwarz; Michael V Van Dyke; Jill Elliot; Briana Barkes; Lee Newman; Lisa Maier
Journal:  J Occup Environ Hyg       Date:  2014       Impact factor: 2.155

2.  Biological exposure metrics of beryllium-exposed dental technicians.

Authors:  Moshe Stark; Yehuda Lerman; Arik Kapel; Asher Pardo; Yehuda Schwarz; Lee Newman; Lisa Maier; Elizabeth Fireman
Journal:  Arch Environ Occup Health       Date:  2014       Impact factor: 1.663

3.  Induced sputum as a method for detection of systemic sclerosis-related interstitial lung disease.

Authors:  Neslihan Yilmaz; Yasin Abul; Muge Bicakcigil; Pejman Golabi; Cigdem Celikel; Sait Karakurt; Sule Yavuz
Journal:  Rheumatol Int       Date:  2011-03-30       Impact factor: 2.631

4.  Hydrogen peroxide in exhaled breath condensate (EBC) vs eosinophil count in induced sputum (IS) in parenchymal vs airways lung diseases.

Authors:  Elizabeth Fireman; Moshe Shtark; Israel E Priel; Robert Shiner; Ram Mor; Shmuel Kivity; Zvi Fireman
Journal:  Inflammation       Date:  2007-04       Impact factor: 4.092

5.  Induced sputum proteome in healthy subjects and asthmatic patients.

Authors:  Sina A Gharib; Elizabeth V Nguyen; Ying Lai; Jessica D Plampin; David R Goodlett; Teal S Hallstrand
Journal:  J Allergy Clin Immunol       Date:  2011-09-08       Impact factor: 10.793

6.  Is Induced Sputum A Useful Noninvasive Tool in the Diagnosis of Pulmonary Sarcoidosis?

Authors:  Ayşe Baha; Fatma Yıldırım; Moshe Stark; Ayşe Kalkancı; Elizabeth Fireman; Nurdan Köktürk
Journal:  Turk Thorac J       Date:  2019-08-19

7.  Mucosal-associated invariant T cells and Vδ2+ γδ T cells in community acquired pneumonia: association of abundance in sputum with clinical severity and outcome.

Authors:  R F Hannaway; X Wang; M Schneider; S Slow; J Cowan; B Brockway; M R Schofield; X C Morgan; D R Murdoch; J E Ussher
Journal:  Clin Exp Immunol       Date:  2019-10-24       Impact factor: 4.330

8.  Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases.

Authors:  E Fireman; Z Kraiem; O Sade; J Greif; Z Fireman
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

9.  Induced sputum assessment in New York City firefighters exposed to World Trade Center dust.

Authors:  Elizabeth M Fireman; Yehuda Lerman; Eliezer Ganor; Joel Greif; Sharon Fireman-Shoresh; Paul J Lioy; Gisela I Banauch; Michael Weiden; Kerry J Kelly; David J Prezant
Journal:  Environ Health Perspect       Date:  2004-11       Impact factor: 9.031

10.  Rapid diagnosis of smear-negative tuberculosis using immunology and microbiology with induced sputum in HIV-infected and uninfected individuals.

Authors:  Ronan A M Breen; Gareth A D Hardy; Felicity M R Perrin; Sara Lear; Sabine Kinloch; Colette J Smith; Ian Cropley; George Janossy; Marc C I Lipman
Journal:  PLoS One       Date:  2007-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.